|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vanneman M and Dranoff G: Combining
immunotherapy and targeted therapies in cancer treatment. Nat Rev
Cancer. 12:237–251. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nicolini A, Giardino R, Carpi A, Ferrari
P, Anselmi L, Colosimo S, Conte M, Fini M, Giavaresi G, Berti P, et
al: Metastatic breast cancer: An updating. Biomed Pharmacother.
60:548–556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rubens RD: 7. Management of advanced
breast cancer. Int J Clin Pract. 55:676–679. 2001.
|
|
6
|
Yardley DA: Visceral disease in patients
with metastatic breast cancer: Efficacy and safety of treatment
with ixabepilone and other chemotherapeutic agents. Clin Breast
Cancer. 10:64–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao H, Xu E, Liu H, Wan L and Lai M:
Epithelial-mesenchymal transition in colorectal cancer metastasis:
A system review. Pathol Res Pract. 211:557–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scheel C and Weinberg RA: Cancer stem
cells and epithelial-mesenchymal transition: Concepts and molecular
links. Semin Cancer Biol. 22:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shook D and Keller R: Mechanisms,
mechanics and function of epithelial-mesenchymal transitions in
early development. Mech Dev. 120:1351–1383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thiery JP and Lim CT: Tumor dissemination:
An EMT affair. Cancer Cell. 23:272–273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bill R and Christofori G: The relevance of
EMT in breast cancer metastasis: Correlation or causality? FEBS
Lett. 589:1577–1587. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar
|
|
15
|
Armstrong AJ, Marengo MS, Oltean S, Kemeny
G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ and
Garcia-Blanco MA: Circulating tumor cells from patients with
advanced prostate and breast cancer display both epithelial and
mesenchymal markers. Mol Cancer Res. 9:997–1007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Y, Sarkissyan M and Vadgama JV:
Epithelial-mesenchymal transition and breast cancer. J Clin Med.
5:pii: E13. 2016. View Article : Google Scholar
|
|
17
|
Sgarbossa A, Giacomazza D and di Carlo M:
Ferulic Acid: A hope for Alzheimer's disease therapy from plants.
Nutrients. 7:5764–5782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanski J, Aksenova M, Stoyanova A and
Butterfield DA: Ferulic acid antioxidant protection against
hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal
cell culture systems in vitro: Structure-activity studies. J Nutr
Biochem. 13:273–281. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mancuso C and Santangelo R: Ferulic acid:
Pharmacological and toxicological aspects. Food Chem Toxicol.
65:185–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Janicke B, Hegardt C, Krogh M, Onning G,
Akesson B, Cirenajwis HM and Oredsson SM: The antiproliferative
effect of dietary fiber phenolic compounds ferulic acid and
p-coumaric acid on the cell cycle of Caco-2 cells. Nutr Cancer.
63:611–622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alam MA, Sernia C and Brown L: Ferulic
acid improves cardiovascular and kidney structure and function in
hypertensive rats. J Cardiovasc Pharmacol. 61:240–249. 2013.
View Article : Google Scholar
|
|
22
|
Roy S, Metya SK, Sannigrahi S, Rahaman N
and Ahmed F: Treatment with ferulic acid to rats with
streptozotocin-induced diabetes: Effects on oxidative stress,
pro-inflammatory cytokines, and apoptosis in the pancreatic β cell.
Endocrine. 44:369–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin FH, Lin JY, Gupta RD, Tournas JA,
Burch JA, Selim MA, Monteiro-Riviere NA, Grichnik JM, Zielinski J
and Pinnell SR: Ferulic acid stabilizes a solution of vitamins C
and E and doubles its photoprotection of skin. J Invest Dermatol.
125:826–832. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jayaprakasam B, Vanisree M, Zhang Y,
Dewitt DL and Nair MG: Impact of alkyl esters of caffeic and
ferulic acids on tumor cell proliferation, cyclooxygenase enzyme,
and lipid peroxidation. J Agric Food Chem. 54:5375–5381. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cole L, Anderson M, Antin PB and Limesand
SW: One process for pancreatic beta-cell coalescence into islets
involves an epithelial-mesenchymal transition. J Endocrinol.
203:19–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gomes LR, Terra LF, Sogayar MC and
Labriola L: Epithelial-mesenchymal transition: Implications in
cancer progression and metastasis. Curr Pharm Biotechnol.
12:1881–1890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bolós V, Peinado H, Pérez-Moreno MA, Fraga
MF, Esteller M and Cano A: The transcription factor Slug represses
E-cadherin expression and induces epithelial to mesenchymal
transitions: A comparison with Snail and E47 repressors. J Cell
Sci. 116:499–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eger A, Aigner K, Sonderegger S, Dampier
B, Oehler S, Schreiber M, Berx G, Cano A, Beug H and Foisner R:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ikenouchi J, Matsuda M, Furuse M and
Tsukita S: Regulation of tight junctions during the
epithelium-mesenchyme transition: Direct repression of the gene
expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martínez-Estrada OM, Cullerés A, Soriano
FX, Peinado H, Bolós V, Martínez FO, Reina M, Cano A, Fabre M and
Vilaró S: The transcription factors Slug and Snail act as
repressors of Claudin-1 expression in epithelial cells. Biochem J.
394:449–457. 2006. View Article : Google Scholar :
|
|
34
|
Barone E, Calabrese V and Mancuso C:
Ferulic acid and its therapeutic potential as a hormetin for
age-related diseases. Biogerontology. 10:97–108. 2009. View Article : Google Scholar
|
|
35
|
Adluri RS, Nagarajan D, Periyaswamy V and
Venugopal PM: Dose-response effect of ferulic acid against
nicotine-induced tissue damage and altered lipid levels in
experimental rats: A pathohistological evaluation. Fundam Clin
Pharmacol. 22:557–567. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sudheer AR, Muthukumaran S, Kalpana C,
Srinivasan M and Menon VP: Protective effect of ferulic acid on
nicotine-induced DNA damage and cellular changes in cultured rat
peripheral blood lymphocytes: A comparison with N-acetylcysteine.
Toxicol In Vitro. 21:576–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thompson EW, Torri J, Sabol M, Sommers CL,
Byers S, Valverius EM, Martin GR, Lippman ME, Stampfer MR and
Dickson RB: Oncogene-induced basement membrane invasiveness in
human mammary epithelial cells. Clin Exp Metastasis. 12:181–194.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brabletz T, Jung A, Hermann K, Günther K,
Hohenberger W and Kirchner T: Nuclear overexpression of the
oncoprotein beta-catenin in colorectal cancer is localized
predominantly at the invasion front. Pathol Res Pract. 194:701–704.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xue C, Plieth D, Venkov C, Xu C and
Neilson EG: The gatekeeper effect of epithelial-mesenchymal
transition regulates the frequency of breast cancer metastasis.
Cancer Res. 63:3386–3394. 2003.PubMed/NCBI
|
|
41
|
Dave B, Mittal V, Tan N; Toxicol In Vitro
M; Chang JC: Epithelial-mesenchymal transition, cancer stem cells
and treatment resistance. Breast Cancer Res. 14:2022012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar
|
